首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1297783

全球醫療保健分析測試服務市場 - 2023-2030年

Global Healthcare Analytical Testing Services Market - 2023-2030

出版日期: 2023年06月15日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球醫療保健分析測試服務市場在2022年達到64億美元，預計到2030年將見證有利可圖的成長，達到147億美元。在預測期內（2023-2030年），全球醫療保健分析測試服務市場預計將呈現11.1%的複合成長率。

醫療保健分析測試服務通過進行測試來識別潛在的風險，確保醫療設備、藥品和其他保健產品的品質和功效，從而幫助保障病人的安全。這些測試有助於識別污染物，驗證產品的完整性，並檢測任何可能對病人構成威脅的有害物質。

檢測服務有助於評估不同治療方式的有效性。臨床試驗和研究依靠分析測試來衡量治療效果，評估藥物在體內的濃度，並評估疾病進展或治療反應的生物標記。

市場動態

實驗室檢測服務外包的趨勢將推動市場成長

由於實驗室檢測服務外包趨勢的上升，各公司正通過提供各種服務和解決方案來擴大其市場佔有率。主要的參與者也在專注於其他戰略，包括合併、收購和其他進展。

例如，2021年8月，為了擴大其在日本的測試產品範圍，歐陸集團與Noritsu Koki有限公司簽訂了一份契約。由於生物分析測試服務至關重要，該市場預計將迅速成長。因此，知名企業的擴張戰略促進了市場的成長。

傳染性疾病發病率的增加將推動市場的成長

登革熱、艾滋病毒等傳染病發病率的增加將推動市場的成長。例如，根據世界衛生組織的數據，登革熱病毒（DENV）感染了叮咬人的蚊子，導致了被稱為登革熱的病毒感染。現在世界上大約有一半的人口面臨著登革熱的風險，據認為每年會有1-5億人感染。登革熱是一種熱帶和亞熱帶疾病，主要影響城市和半城市環境。儘管由於傳染病在增加，它必須在實驗室進行分析，但醫療分析測試服務的市場將在未來幾年擴大。

數據不安全將阻礙市場的成長。

解決醫療分析測試服務中的數據不安全問題需要一個多方面的方法，包括強大的網路安全措施、定期安全評估、員工培訓和遵守相關法規。對醫療機構來說，投資於保護病人數據並在面對不斷變化的網路威脅時保持警惕是至關重要的。因此，上述因素限制了市場的成長。

COVID-19影響分析

COVID-19大流行病對醫療分析測試服務產生了重大影響。它導致了測試需求的增加，加速了新測試方法和技術的採用，使實驗室資源緊張，並重新調整了優先事項。儘管有這些挑戰，大流行病也刺激了創新和合作，推動了測試方法的進步以及自動化和人工智慧與醫療分析測試服務的整合。

俄烏戰爭影響分析

俄羅斯-烏克蘭衝突估計對全球醫療分析測試服務市場的影響不大，因為該地區的主要市場參與者數量較少。然而，在預測期內，原料進出口的影響預計對全球醫療保健分析測試服務市場的成長影響不大。

人工智慧影響分析

人工智慧驅動的算法可以非常精確地分析醫療圖像，如X光、CT掃描和MRI。深度學習算法可以檢測出人類專家可能難以識別的異常情況、病變和模式。這有助於放射科醫生做出準確的診斷，減少錯誤，並改善病人的治療效果。人工智慧在醫療保健分析測試服務方面具有顯著優勢，從數據分析和解釋到預測分析、圖像分析、基因組分析、藥物發現、品質控制和工作流程最佳化。

Market Overview

The Global Healthcare Analytical Testing Services Market reached US$ 6.4 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 14.7 billion by 2030. The global Healthcare Analytical Testing Services Market is expected to exhibit a CAGR of 11.1% during the forecast period (2023-2030).

Healthcare analytical testing services help safeguard patient safety by conducting tests to identify potential risks and ensure the quality and efficacy of medical devices, pharmaceuticals, and other healthcare products. These tests help identify contaminants, verify product integrity, and detect any harmful substances that could pose a threat to patients.

Testing services contribute to evaluating the effectiveness of different treatment modalities. Clinical trials and studies rely on analytical testing to measure treatment outcomes, assess drug concentrations in the body, and evaluate biomarkers of disease progression or treatment response.

Market Dynamics

Rising Trend of Outsourcing Laboratory Testing Services Will Drive The Market Growth

Companies are growing their market share by providing a variety of services and solutions as a result of the rising trend of outsourcing laboratory testing services. Major players are also concentrating on other strategies, including mergers, acquisitions, and other advances.

For instance, in August 2021, to increase the scope of its testing offerings in Japan, Eurofins Scientific entered into a contract with Noritsu Koki Co. Ltd to purchase GeneTech Inc., a major participant in genetic analysis in Japan.The market is expected to increase rapidly since the bioanalytical testing service is crucial. Therefore, prominent players' expanding strategies contribute to the growth of the market.

Increasing Prevalence Of Infectious Diseases Will Drive The Market Growth

The increasing prevalence of infectious diseases like dengue, HIV and others will drive the market growth. For instance, according to WHO, the dengue virus (DENV), which infects mosquitoes that bite people, causes the viral infection known as dengue. Approximately half of the world's population is now at risk for dengue, with 100-500 million infections thought to occur annually. Dengue is a tropical and subtropical disease that primarily affects urban and semi-urban settings. Although it must be analyzed in laboratories since infectious diseases are on the rise, the market for healthcare analytical testing services will expand in the next years.

Data Insecurity Will Hamper The Market Growth.

Addressing data insecurity in healthcare analytical testing services requires a multi-faceted approach involving robust cybersecurity measures, regular security assessments, employee training, and compliance with relevant regulations. It is crucial for healthcare organizations to invest in the protection of patient data and stay vigilant in the face of evolving cyber threats. Thus above factors restrict the market growth.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on healthcare analytical testing services. It led to increased testing demand, accelerated the adoption of new testing methods and technologies, strained laboratory resources, and reshaped priorities. Despite the challenges, the pandemic also spurred innovation and collaboration, driving advancements in testing methodologies and the integration of automation and AI into healthcare analytical testing services.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global Healthcare Analytical Testing Services market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global Healthcare Analytical Testing Servicesmarket growth over the forecast period.

Artificial Intelligence Impact Analysis

AI-powered algorithms can analyze medical images, such as X-rays, CT scans, and MRIs, with remarkable precision. Deep learning algorithms can detect anomalies, lesions, and patterns that might be difficult for human experts to identify. This assists radiologists in making accurate diagnoses, reducing errors, and improving patient outcomes. AI offers significant advantages in healthcare analytical testing services, ranging from data analysis and interpretation to predictive analytics, image analysis, genomic analysis, drug discovery, quality control, and workflow optimization.

Segment Analysis

The global healthcare analytical testing servicesmarket is segmented based on test type, end user and region.

Pharmaceutical & Biopharmaceutical Companies from End user Segment Accounts for 38.3% of Market Share.

The strategies of the key players will dominate the segment's growth. For instance, on October 24, 2022, as part of its $97 million expansion, Thermo Fisher added a clinical research facility.

The business establishes a bioanalytical lab in the US, adding 59,000 square feet of additional space to the facility overall, making it "one of the largest laboratories of its kind." The new bioanalytical facility is part of a $97 million (€99 million) total investment that Thermo Fisher will make at the Richmond, Virginia, location. The lab will be utilized to offer laboratory services in the drug development process, the company claims. As a result, market growth will be dominated by key players' company expansion and collaboration.

Geographical Analysis

Asia Pacific Accounted for Approximately 25.4% of the Market Share

Due to increased investments made in improving regional analytical services by businesses from developed economies, changes made to evaluation standards by regulatory bodies to bring them into line with international standards, and the creation of new facilities and alliances to expand the reach of their offerings to different regions in the region.

For instance, on May 19, 2021, Leading global life sciences company announced the addition of bioanalytical services in Singapore to its drug development offering in the Asia-Pacific region. And Singapore is a significant region for bolstering Labcorp's vast global presence because it provides clients of the company with a complementary site to support their bioanalytical research, both domestically and internationally.

Additionally, August 04, 2021, TetraQ has been acquired by Agilex Biolabs as part of its APAC expansion plans. Agilex Biolabs specialises in the bioanalysis of biologics and small compounds for PK, immunogenicity, biomarker, and immunological pharmacodynamics assessments. With its knowledgeable workforce and decades of experience in regulated bioanalytical services, TetraQ complements the work of Agilex Biolabs in Australia and the APAC region. Thus, the aforementioned variables predominate market growth.

Competitive Landscape

The major global players in the healthcare analytical testing services market include: Pharmaceutical Product Development, LLC (PPD), Eurofins Scientific, SGS SA, Toxikon Inc., Pace Analytical Services, Intertek Pharmaceutical Services, Boston Analytical, West Pharmaceutical Services Inc., Steris, Charles River Laboratories and among others.

Why Purchase the Report?

To visualize the global healthcare analytical testing services market segmentation based on test type, end user and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of Healthcare Analytical Testing Services market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global Healthcare Analytical Testing Services market report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Test Type
3.2. Snippet by End User
3.3. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising clinical trials will drive the market growth
  - 4.1.1.2. Increasing growth for bioanalytical testing services
- 4.1.2. Restraints
  - 4.1.2.1. Data Insecurity will hamper the market growth
- 4.1.3. Opportunity
  - 4.1.3.1. The increasing focus on preventive healthcare and early disease detection
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. Artificial Intelligence Impact

8. ByTest Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 8.1.2. Market Attractiveness Index, By Test Type
8.2. Bioanalytical Testing Services*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Method Development & Validation
8.4. Stability Testing
8.5. Drug Substances
8.6. Others

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Pharmaceutical & Biopharmaceutical Companies*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Medical Device Companies
9.4. Contract Research Organizations
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.5.1. The U.S.
  - 10.2.5.2. Canada
  - 10.2.5.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.5.1. Germany
  - 10.3.5.2. The U.K.
  - 10.3.5.3. France
  - 10.3.5.4. Spain
  - 10.3.5.5. Italy
  - 10.3.5.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.5.1. Brazil
  - 10.4.5.2. Argentina
  - 10.4.5.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.5.1. China
  - 10.5.5.2. India
  - 10.5.5.3. Japan

Australia

10.5.5.4. Rest of Asia-Pacific

10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Pharmaceutical Product Development, LLC (PPD)*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Eurofins Scientific
12.3. SGS SA
12.4. Toxikon Inc.
12.5. Pace Analytical Services
12.6. Intertek Pharmaceutical Services
12.7. Boston Analytical
12.8. West Pharmaceutical Services Inc.
12.9. Steris
12.10. Charles River Laboratories.

LIST NOT EXHAUSTIVE